Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Julphar
Queensland Health
Boehringer Ingelheim
Teva
Daiichi Sankyo
AstraZeneca
Mallinckrodt
US Army

Generated: May 21, 2018

DrugPatentWatch Database Preview

Kythera Biopharms Company Profile

« Back to Dashboard

What is the competitive landscape for KYTHERA BIOPHARMS, and what generic alternatives to KYTHERA BIOPHARMS drugs are available?

KYTHERA BIOPHARMS has one approved drug.

There are thirteen US patents protecting KYTHERA BIOPHARMS drugs.

There are eighty-four patent family members on KYTHERA BIOPHARMS drugs in thirty countries and three supplementary protection certificates in three countries.

Summary for Kythera Biopharms
International Patents:84
US Patents:13
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Kythera Biopharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kythera Biopharms KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 RX Yes Yes 7,754,230 ➤ Try a Free Trial ➤ Try a Free Trial
Kythera Biopharms KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 RX Yes Yes 8,546,367 ➤ Try a Free Trial Y ➤ Try a Free Trial
Kythera Biopharms KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 RX Yes Yes 8,298,556 ➤ Try a Free Trial ➤ Try a Free Trial
Kythera Biopharms KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 RX Yes Yes 8,101,593 ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Kythera Biopharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,737,549 Formulations of deoxycholic acid and salts thereof ➤ Try a Free Trial
9,050,349 Synthetic bile acid compositions and methods ➤ Try a Free Trial
7,902,387 Preparation of bile acids and intermediates thereof ➤ Try a Free Trial
9,186,364 Formulations of deoxycholic acid and salts thereof ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for Kythera Biopharms Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2017 00067 Denmark ➤ Try a Free Trial PRODUCT NAME: DEOXYCHOLSYRE NATRIUMSALT; NAT. REG. NO/DATE: 59040 20170703; FIRST REG. NO/DATE: IS IS/1/16/071/01 20160729
2017006 Lithuania ➤ Try a Free Trial PRODUCT NAME: DEZOKSICHOLIO RUGSTIES NATRIO DRUSKA; REGISTRATION NO/DATE: LT/1/16/3960/001 20160909
0907 Netherlands ➤ Try a Free Trial PRODUCT NAME: DEOXYCHOLINEZUUR NATRIUMZOUT
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Queensland Health
US Department of Justice
Daiichi Sankyo
Merck
Johnson and Johnson
AstraZeneca
Cerilliant
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.